164 related articles for article (PubMed ID: 32221780)
1. Large-scale evaluation of cytochrome P450 2C9 mediated drug interaction potential with machine learning-based consensus modeling.
Rácz A; Keserű GM
J Comput Aided Mol Des; 2020 Aug; 34(8):831-839. PubMed ID: 32221780
[TBL] [Abstract][Full Text] [Related]
2. In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9.
Nembri S; Grisoni F; Consonni V; Todeschini R
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294921
[TBL] [Abstract][Full Text] [Related]
3. In Silico Predictions of Drug - Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition - a Comparative Study of Virtual Screening Performance.
Kaserer T; Höferl M; Müller K; Elmer S; Ganzera M; Jäger W; Schuster D
Mol Inform; 2015 Jun; 34(6-7):431-57. PubMed ID: 27490388
[TBL] [Abstract][Full Text] [Related]
4. Machine learning-driven identification of drugs inhibiting cytochrome P450 2C9.
Goldwaser E; Laurent C; Lagarde N; Fabrega S; Nay L; Villoutreix BO; Jelsch C; Nicot AB; Loriot MA; Miteva MA
PLoS Comput Biol; 2022 Jan; 18(1):e1009820. PubMed ID: 35081108
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2C9-natural antiarthritic interactions: Evaluation of inhibition magnitude and prediction from in vitro data.
Tan BH; Ahemad N; Pan Y; Palanisamy UD; Othman I; Yiap BC; Ong CE
Biopharm Drug Dispos; 2018 Apr; 39(4):205-217. PubMed ID: 29488228
[TBL] [Abstract][Full Text] [Related]
6. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers.
Cheng F; Yu Y; Shen J; Yang L; Li W; Liu G; Lee PW; Tang Y
J Chem Inf Model; 2011 May; 51(5):996-1011. PubMed ID: 21491913
[TBL] [Abstract][Full Text] [Related]
7. Construction of Metabolism Prediction Models for CYP450 3A4, 2D6, and 2C9 Based on Microsomal Metabolic Reaction System.
He SB; Li MM; Zhang BX; Ye XT; Du RF; Wang Y; Qiao YJ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27735849
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytochrome P450 2C9 expression and activity in vitro by allyl isothiocyanate.
Lim YP; Chen WC; Cheng CH; Ma WC; Lin YH; Chen CY; Hung DZ; Chen JJ; Yokoi T; Nakajima M; Chen CJ
Planta Med; 2014 Aug; 80(13):1097-106. PubMed ID: 25197954
[TBL] [Abstract][Full Text] [Related]
9. Efavirenz clearances in vitro and in vivo in six cynomolgus monkeys associated with polymorphic cytochrome P450 2C9 and simulated by individual physiologically based pharmacokinetic models.
Utoh M; Miura T; Kusama T; Uehara S; Shimizu M; Uno Y; Yamazaki H
Biopharm Drug Dispos; 2017 Oct; 38(7):439-442. PubMed ID: 28608515
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of machine learning models for cytochrome P450 3A4, 2D6, and 2C9 inhibition.
Gong C; Feng Y; Zhu J; Liu G; Tang Y; Li W
J Appl Toxicol; 2024 Mar; ():. PubMed ID: 38544296
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes.
Wang Z; Sun W; Huang CK; Wang L; Xia MM; Cui X; Hu GX; Wang ZS
Drug Dev Ind Pharm; 2015 Apr; 41(4):613-6. PubMed ID: 24517573
[TBL] [Abstract][Full Text] [Related]
12. Differing Membrane Interactions of Two Highly Similar Drug-Metabolizing Cytochrome P450 Isoforms: CYP 2C9 and CYP 2C19.
Mustafa G; Nandekar PP; Bruce NJ; Wade RC
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487853
[TBL] [Abstract][Full Text] [Related]
13. In silico prediction of multiple-category classification model for cytochrome P450 inhibitors and non-inhibitors using machine-learning method.
Lee JH; Basith S; Cui M; Kim B; Choi S
SAR QSAR Environ Res; 2017 Oct; 28(10):863-874. PubMed ID: 29183231
[TBL] [Abstract][Full Text] [Related]
14. Prediction of the Impact of Cytochrome P450 2C9 Genotypes on the Drug-Drug Interaction Potential of Siponimod With Physiologically-Based Pharmacokinetic Modeling: A Comprehensive Approach for Drug Label Recommendations.
Huth F; Gardin A; Umehara K; He H
Clin Pharmacol Ther; 2019 Nov; 106(5):1113-1124. PubMed ID: 31199498
[TBL] [Abstract][Full Text] [Related]
15. Using chemical bond-based method to predict site of metabolism for five biotransformations mediated by CYP 3A4, 2D6, and 2C9.
Fu X; He S; Du L; Lv Z; Zhang Y; Zhang Q; Wang Y
Biochem Pharmacol; 2018 Jun; 152():302-314. PubMed ID: 29588194
[TBL] [Abstract][Full Text] [Related]
16. Effect of 95% Ethanol Khat Extract and Cathinone on in vitro Human Recombinant Cytochrome P450 (CYP) 2C9, CYP2D6, and CYP3A4 Activity.
Lim SYM; Binti Azidin AR; Ung YT; Al-Shagga M; Alshawsh MA; Mohamed Z; Ong CE; Pan Y
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):423-431. PubMed ID: 30306496
[TBL] [Abstract][Full Text] [Related]
17. CYPstrate: A Set of Machine Learning Models for the Accurate Classification of Cytochrome P450 Enzyme Substrates and Non-Substrates.
Holmer M; de Bruyn Kops C; Stork C; Kirchmair J
Molecules; 2021 Aug; 26(15):. PubMed ID: 34361831
[TBL] [Abstract][Full Text] [Related]
18. Harnessing machine learning to predict cytochrome P450 inhibition through molecular properties.
Zahid H; Tayara H; Chong KT
Arch Toxicol; 2024 Apr; ():. PubMed ID: 38619593
[TBL] [Abstract][Full Text] [Related]
19. Insights into molecular basis of cytochrome p450 inhibitory promiscuity of compounds.
Cheng F; Yu Y; Zhou Y; Shen Z; Xiao W; Liu G; Li W; Lee PW; Tang Y
J Chem Inf Model; 2011 Oct; 51(10):2482-95. PubMed ID: 21875141
[TBL] [Abstract][Full Text] [Related]
20. Case Study 9: Probe-Dependent Binding Explains Lack of CYP2C9 Inactivation by 1-Aminobenzotriazole (ABT).
Sodhi JK; Halladay JS
Methods Mol Biol; 2021; 2342():765-779. PubMed ID: 34272716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
